CN103751310A - 一种治疗筋膜炎的中药外用制剂及其制备方法 - Google Patents
一种治疗筋膜炎的中药外用制剂及其制备方法 Download PDFInfo
- Publication number
- CN103751310A CN103751310A CN201310753567.1A CN201310753567A CN103751310A CN 103751310 A CN103751310 A CN 103751310A CN 201310753567 A CN201310753567 A CN 201310753567A CN 103751310 A CN103751310 A CN 103751310A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- preparation
- fascitis
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010016228 Fasciitis Diseases 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 239000003814 drug Substances 0.000 claims abstract description 85
- 239000004863 Frankincense Substances 0.000 claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 21
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- 241000903946 Clematidis Species 0.000 claims abstract description 14
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims description 58
- 241000180649 Panax notoginseng Species 0.000 claims description 37
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 37
- 241000717739 Boswellia sacra Species 0.000 claims description 26
- 241001057584 Myrrha Species 0.000 claims description 25
- 239000002674 ointment Substances 0.000 claims description 23
- 241000628997 Flos Species 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 241000208152 Geranium Species 0.000 claims description 15
- 241000237636 Pheretima Species 0.000 claims description 15
- 241001489978 Eupolyphaga Species 0.000 claims description 14
- 238000002425 crystallisation Methods 0.000 claims description 14
- 230000008025 crystallization Effects 0.000 claims description 14
- 238000004821 distillation Methods 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 13
- 230000003203 everyday effect Effects 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 230000002829 reductive effect Effects 0.000 claims description 7
- 241001446509 Psoralea Species 0.000 claims description 6
- 239000007766 cera flava Substances 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000005496 tempering Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 239000000571 coke Substances 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 206010049949 Intercostal neuralgia Diseases 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 229940099259 vaseline Drugs 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 86
- 230000036407 pain Effects 0.000 abstract description 84
- 230000000694 effects Effects 0.000 abstract description 62
- 230000017531 blood circulation Effects 0.000 abstract description 25
- 210000000988 bone and bone Anatomy 0.000 abstract description 17
- 239000011505 plaster Substances 0.000 abstract description 16
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 230000035876 healing Effects 0.000 abstract description 4
- 230000008506 pathogenesis Effects 0.000 abstract description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000387101 Erodium stephanianum Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000010415 tropism Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 95
- 210000004369 blood Anatomy 0.000 description 86
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 39
- 201000010099 disease Diseases 0.000 description 38
- 210000003734 kidney Anatomy 0.000 description 29
- 210000003205 muscle Anatomy 0.000 description 27
- 238000000034 method Methods 0.000 description 26
- 230000001737 promoting effect Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 21
- 208000006820 Arthralgia Diseases 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 18
- 238000001467 acupuncture Methods 0.000 description 17
- 208000037920 primary disease Diseases 0.000 description 17
- 239000000463 material Substances 0.000 description 16
- 208000014674 injury Diseases 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 14
- 210000001015 abdomen Anatomy 0.000 description 14
- 230000000202 analgesic effect Effects 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 201000000736 Amenorrhea Diseases 0.000 description 12
- 206010001928 Amenorrhoea Diseases 0.000 description 12
- 206010019233 Headaches Diseases 0.000 description 12
- 231100000540 amenorrhea Toxicity 0.000 description 12
- 210000003195 fascia Anatomy 0.000 description 12
- 231100000869 headache Toxicity 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 12
- 210000001624 hip Anatomy 0.000 description 11
- 208000005392 Spasm Diseases 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 208000008035 Back Pain Diseases 0.000 description 9
- 208000025747 Rheumatic disease Diseases 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 230000000552 rheumatic effect Effects 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 210000002435 tendon Anatomy 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 208000019255 Menstrual disease Diseases 0.000 description 8
- 206010027514 Metrorrhagia Diseases 0.000 description 8
- 208000007101 Muscle Cramp Diseases 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 230000008736 traumatic injury Effects 0.000 description 8
- 206010000087 Abdominal pain upper Diseases 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 208000008930 Low Back Pain Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 230000001771 impaired effect Effects 0.000 description 7
- 230000002175 menstrual effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000010792 warming Methods 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 6
- 230000009545 invasion Effects 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 206010040872 skin infection Diseases 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000004089 microcirculation Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 206010042772 syncope Diseases 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 208000004044 Hypesthesia Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010024453 Ligament sprain Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000010040 Sprains and Strains Diseases 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 238000011443 conventional therapy Methods 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 208000024756 faint Diseases 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 208000034783 hypoesthesia Diseases 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000003387 muscular Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 231100000041 toxicology testing Toxicity 0.000 description 4
- 206010063659 Aversion Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 208000002740 Muscle Rigidity Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 206010047642 Vitiligo Diseases 0.000 description 3
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 201000009890 sinusitis Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 206010052443 Myofascitis Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000037114 Symptom Flare Up Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009692 acute damage Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000009693 chronic damage Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000009519 contusion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000281 joint capsule Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 208000009146 rhinoscleroma Diseases 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000203233 Aspergillus versicolor Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 1
- 241001427554 Corydiidae Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001489980 Eupolyphaga sinensis Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000036581 Haemorrhagic anaemia Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 1
- -1 Panaxadiol saponin Chemical class 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010065954 Stubbornness Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 240000000920 Typhonium flagelliforme Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- HVYLDJKDVOOTHV-UHFFFAOYSA-N acetic acid;2-iminoethanethiol Chemical compound CC(O)=O.CC(O)=O.SCC=N HVYLDJKDVOOTHV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001618 algogenic effect Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000005308 flint glass Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000002311 liver mitochondria Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000002097 psoas muscle Anatomy 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 208000000029 referred pain Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 40 | 21(52.5) | 12(30) | 4(10) | 3(7.5) | 92.5 |
对照组 | 40 | 15(37.5) | 11(27.5) | 6(15) | 8(20) | 80 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310753567.1A CN103751310B (zh) | 2013-12-31 | 2013-12-31 | 一种治疗筋膜炎的中药外用制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310753567.1A CN103751310B (zh) | 2013-12-31 | 2013-12-31 | 一种治疗筋膜炎的中药外用制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103751310A true CN103751310A (zh) | 2014-04-30 |
CN103751310B CN103751310B (zh) | 2016-06-08 |
Family
ID=50518737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310753567.1A Active CN103751310B (zh) | 2013-12-31 | 2013-12-31 | 一种治疗筋膜炎的中药外用制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103751310B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189672A (zh) * | 2014-08-18 | 2014-12-10 | 史洪松 | 一种治疗筋膜炎的药膏 |
CN105412840A (zh) * | 2015-12-25 | 2016-03-23 | 青岛市第三人民医院 | 一种治疗膝关节滑囊炎的外用贴膏及其制备方法 |
CN105434782A (zh) * | 2015-12-25 | 2016-03-30 | 青岛市第三人民医院 | 一种缓解背肌筋膜炎的按摩药油及其制备方法 |
CN105920130A (zh) * | 2016-07-12 | 2016-09-07 | 杨高林 | 治疗足跟痛的中药制备方法及其外用膏剂 |
CN105943949A (zh) * | 2016-06-25 | 2016-09-21 | 丁常燕 | 一种治疗背肌筋膜炎的中药组合物 |
CN105998246A (zh) * | 2016-07-12 | 2016-10-12 | 杨高林 | 一种治疗足跟痛的中药外用膏剂及其制备方法 |
CN113499373A (zh) * | 2021-08-30 | 2021-10-15 | 陕西中医药大学附属医院 | 用于治疗足底筋膜炎的中药混悬液及应用 |
CN114177130A (zh) * | 2021-12-20 | 2022-03-15 | 李叙诺 | 肌筋膜炎外用制剂及其制备方法和应用 |
CN115737730A (zh) * | 2022-11-17 | 2023-03-07 | 南京中医药大学 | 一种用于治疗足底筋膜炎的中药组合物及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1400007A (zh) * | 2002-06-10 | 2003-03-05 | 郭好建 | 一种治疗骨关节疾病的口服中药 |
CN1452995A (zh) * | 2002-04-26 | 2003-11-05 | 鲍自立 | 治疗骨折、筋伤的外敷膏及其配制方法 |
CA2385271A1 (en) * | 2002-05-22 | 2003-11-22 | Chen Wang | The powder for the root-cultivation, elimination of disaster and longevity |
CN1923234A (zh) * | 2005-08-29 | 2007-03-07 | 刘蕾蕾 | 一种治疗骨关节疾病的中药制剂 |
CN102648953A (zh) * | 2012-03-14 | 2012-08-29 | 孙殿站 | 一种治疗风湿骨病外用药酒 |
CN103340976A (zh) * | 2013-06-18 | 2013-10-09 | 温旌国 | 一种治疗颈间腰腿痛的药剂 |
-
2013
- 2013-12-31 CN CN201310753567.1A patent/CN103751310B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1452995A (zh) * | 2002-04-26 | 2003-11-05 | 鲍自立 | 治疗骨折、筋伤的外敷膏及其配制方法 |
CA2385271A1 (en) * | 2002-05-22 | 2003-11-22 | Chen Wang | The powder for the root-cultivation, elimination of disaster and longevity |
CN1400007A (zh) * | 2002-06-10 | 2003-03-05 | 郭好建 | 一种治疗骨关节疾病的口服中药 |
CN1923234A (zh) * | 2005-08-29 | 2007-03-07 | 刘蕾蕾 | 一种治疗骨关节疾病的中药制剂 |
CN102648953A (zh) * | 2012-03-14 | 2012-08-29 | 孙殿站 | 一种治疗风湿骨病外用药酒 |
CN103340976A (zh) * | 2013-06-18 | 2013-10-09 | 温旌国 | 一种治疗颈间腰腿痛的药剂 |
Non-Patent Citations (3)
Title |
---|
王家余等: "中、西医结合治疗胫腓骨中、下段粉碎性骨折", 《安徽医药》, vol. 12, no. 2, 29 February 2008 (2008-02-29), pages 153 - 154 * |
苏友新: "《中西医结合10个病种临床康复治疗研究》", 31 October 2011, 北京科学技术出版社, article "骨性关节炎", pages: 237 * |
韦英才: "腰背肌筋膜炎的中医外治概况", 《辽宁中医药大学学报》, vol. 10, no. 10, 31 October 2008 (2008-10-31) * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189672A (zh) * | 2014-08-18 | 2014-12-10 | 史洪松 | 一种治疗筋膜炎的药膏 |
CN105412840A (zh) * | 2015-12-25 | 2016-03-23 | 青岛市第三人民医院 | 一种治疗膝关节滑囊炎的外用贴膏及其制备方法 |
CN105434782A (zh) * | 2015-12-25 | 2016-03-30 | 青岛市第三人民医院 | 一种缓解背肌筋膜炎的按摩药油及其制备方法 |
CN105943949A (zh) * | 2016-06-25 | 2016-09-21 | 丁常燕 | 一种治疗背肌筋膜炎的中药组合物 |
CN105920130A (zh) * | 2016-07-12 | 2016-09-07 | 杨高林 | 治疗足跟痛的中药制备方法及其外用膏剂 |
CN105998246A (zh) * | 2016-07-12 | 2016-10-12 | 杨高林 | 一种治疗足跟痛的中药外用膏剂及其制备方法 |
CN113499373A (zh) * | 2021-08-30 | 2021-10-15 | 陕西中医药大学附属医院 | 用于治疗足底筋膜炎的中药混悬液及应用 |
CN114177130A (zh) * | 2021-12-20 | 2022-03-15 | 李叙诺 | 肌筋膜炎外用制剂及其制备方法和应用 |
CN114177130B (zh) * | 2021-12-20 | 2023-09-29 | 李叙诺 | 肌筋膜炎外用制剂及其制备方法和应用 |
CN115737730A (zh) * | 2022-11-17 | 2023-03-07 | 南京中医药大学 | 一种用于治疗足底筋膜炎的中药组合物及其制备方法 |
CN115737730B (zh) * | 2022-11-17 | 2023-08-22 | 南京中医药大学 | 一种用于治疗足底筋膜炎的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103751310B (zh) | 2016-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103751310B (zh) | 一种治疗筋膜炎的中药外用制剂及其制备方法 | |
CN103860667B (zh) | 一种治疗腰肌劳损的中药组合物及其制备方法 | |
CN103751633B (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN101015651A (zh) | 一种治疗椎间盘突出的药物 | |
CN101810685A (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
CN104306495B (zh) | 一种治疗肩周炎的中药外用制剂及其制备方法 | |
CN104666698A (zh) | 一种治疗膝关节滑膜炎的中药外用膏剂及其制备方法 | |
CN113456779A (zh) | 一种按摩涂抹中药药酒及其制备方法和应用 | |
CN102872286B (zh) | 一种治疗腰间盘突出的中药组合物及其制备方法 | |
CN104435169A (zh) | 一种治疗骨伤骨折的中药组合物及其制备方法 | |
CN102626505B (zh) | 基于中草药的按摩膏及其制备方法 | |
CN103751710A (zh) | 一种治疗***不育症的中药组合物及其制备方法 | |
CN103736017A (zh) | 一种治疗肋间神经痛的中药组合物及其制备方法 | |
CN104056076A (zh) | 一种健骨药酒 | |
CN105998246A (zh) | 一种治疗足跟痛的中药外用膏剂及其制备方法 | |
CN110585400A (zh) | 草本通康保健膏 | |
CN103751309B (zh) | 一种治疗肋间神经痛的中药外用制剂及其制备方法 | |
CN112494606A (zh) | 治疗筋骨、风湿类疼痛的中药组合物及其制备方法和应用 | |
CN103100017B (zh) | 一种缓解筋骨疼痛、关节疼痛的中药保健品及其制备方法 | |
CN103860676B (zh) | 一种治疗腰肌劳损的中药外用制剂及其制备方法 | |
CN103751467A (zh) | 一种治疗腰背筋膜炎的中药组合物及其制备方法 | |
CN105999117A (zh) | 用于经络发疱拔罐排毒的中药膏贴的制备及其使用方法 | |
CN104306583A (zh) | 一种治疗月经量少的中药组合物及其制备方法 | |
CN105521391A (zh) | 一种补肝肾强筋骨的中药及其制备方法 | |
CN106074813A (zh) | 一种治疗足跟痛的中药熏洗浸泡剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160509 Address after: The city of Anshan city of Qingdao province Shandong two road 266001 No. 62 Applicant after: Zhao Yumei Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Applicant before: QINGDAO HENGBO INSTRUMENT Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Luan Zhaomin Inventor after: Sun Lifen Inventor after: Shan Lianbin Inventor before: Request for anonymity |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181221 Address after: 401120 Yubei District, Chongqing, Longxi street, Hong Jin Avenue 498, Jiale, Violet 1, 5- business. Patentee after: Chongqing Kaituo Technology Development Co.,Ltd. Address before: 266001 No. 62 A, Anshan Second Road, North District, Qingdao City, Shandong Province Patentee before: Zhao Yumei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201116 Address after: 244000 Huayuan Road, Tongling, Anhui, No. 192 on the first floor Patentee after: Tongling Hailin Management Consulting Co.,Ltd. Address before: 401120 Jiale Ziguang Building 5-Business, 498 Hongjin Avenue, Longxi Street, Yubei District, Chongqing Patentee before: CHONGQING KAITUO TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220928 Address after: No. 4-103-1, Social Mountain South Garden, No. 210, Zhijing Road, Zhangjiawo Town, Xiqing District, Tianjin, 300380 Patentee after: Tianjin Qingyatangya Health Consulting Co.,Ltd. Address before: 244000 1st floor, 192 Huayuan Road, Tongling City, Anhui Province Patentee before: Tongling Hailin Management Consulting Co.,Ltd. |